ArticleCell death and differentiation2025

Targeting the BCKDK/BCLAF1/MYC/HK2 axis to alter aerobic glycolysis and overcome Trametinib resistance in lung cancer.

Hao Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.